ABVC AMER BRIVISION

-

AMER BRIVISION Reported Earnings

Wednesday, August 12, 2026 · 12:00 AM ET

AMER BRIVISION (ABVC) reported a loss of $0.03 per share on revenue of $0.00 million for the . .

ABVC BioPharma Inc. is a clinical-stage biopharmaceutical company developing botanical-based therapies for central nervous system, ophthalmology and oncology/hematology indications. ABVC BioPharma Inc. is based in SILICON VALLEY, CA.

Earnings Whisper Grade
Power Rating
Reported Earnings
($0.03)
Earnings Whisper®
Consensus Estimate
Earnings Surprise
Earnings Growth76.9 %
Reported Revenue
Revenue Estimate
Revenue Surprise
Revenue Growth